Furthermore, miR-155 in tumor cells is associated with transcriptional regulation by FOXP3 through BRCA1, subsequently controlling miR-155 and its targets, such as RAD51. Further, plasma miR-155 may be a tool for non-invasive detection of early-stage breast cancer. The gene discussed is RAD51; the disease is breast cancer.